Profilin-1 promotes the development of hypertension-induced cardiac hypertrophy

Journal of Hypertension

Volumn 31, Issue 3, 2013, Pages 576-586

  Zhao, Shao Hua ^a,b   Qiu, Jie ^a,b   Wang, Yan ^a,b   Ji, Xiang ^a,b   Liu, Xiang Ju ^a   You, Bei An ^a   Sheng, Yu Ping ^a,b   Li, Xiao ^a   Gao, Hai Qing ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Provincial Key Laboratory of Cardiovascular Proteomics   (China)

Author keywords

Caveolae; Endothelial nitric oxide synthase; Hypertrophy; Myocardium; Profilin 1

Indexed keywords

CAVEOLIN 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MICRORNA; NITRIC OXIDE; PHALLOIDIN; PROFILIN; PROFILIN I; UNCLASSIFIED DRUG; PFN1 PROTEIN, RAT; PRIMER DNA;

ACTIN FILAMENT; ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAVEOLA; CONTROLLED STUDY; DISEASE COURSE; GENE OVEREXPRESSION; HEART; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HYPERTENSION; MALE; MUSCLE FIBRIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOLEMMA; STRAIN DIFFERENCE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING; ANIMAL; CARDIOMEGALY; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALS; BASE SEQUENCE; CARDIOMEGALY; DNA PRIMERS; HYPERTENSION; MALE; PROFILINS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84884193916     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835d6a56     Document Type: Article

References (25)

1. Yarmola EG, Bubb MR. How depolymerization can promote polymerization: the case of actin and profilin. Bioessays 2009; 31:1150-1160.
2. Yarmola EG, Bubb MR. Profilin: emerging concepts and lingering misconceptions. Trends Biochem Sci 2006; 31:197-205.
3. Pantaloni D, Carlier MF. How profilin promotes actin filament assembly in the presence of thymosin beta 4. Cell 1993; 75:1007-1014. (Pubitemid 24014557)
4. Korenbaum E, Nordberg P, Bjorkegren-Sjogren C, Schutt CE, Lindberg U, Karlsson R. The role of profilin in actin polymerization and nucleotide exchange. Biochemistry 1998; 37:9274-9283. (Pubitemid 28307681)
5. Zhao SH, Gao HQ, Ji X, Wang Y, Liu XJ, You BA, et al. Effect of ouabain on myocardial ultrastructure and cytoskeleton during the development of ventricular hypertrophy. Heart Vessels 2012 [Epub ahead of print].
6. Moustafa-Bayoumi M, Alhaj MA, El-Sayed O, Wisel S, Chotani MA, Abouelnaga ZA, et al. Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1. J Biol Chem 2007; 282:37632-37639.
7. Hassona MD, Abouelnaga ZA, Elnakish MT, Awad MM, Alhaj M, Goldschmidt-Clermont PJ, Hassanain H. Vascular hypertrophy-associated hypertension of profilin1 transgenic mouse model leads to functional remodeling of peripheral arteries. Am J Physiol Heart Circ Physiol 2010; 298:H2112-H2120.
8. Romeo GR, Moulton KS, Kazlauskas A. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse. Circ Res 2007; 101:357-367. (Pubitemid 47267704)
9. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, et al. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 2004; 94:1256-1262. (Pubitemid 38656413)
10. Wenzel S, Rohde C, Wingerning S, Roth J, Kojda G, Schluter KD. Lack of endothelial nitric oxide synthase-derived nitric oxide formation favors hypertrophy in adult ventricular cardiomyocytes. Hypertension 2007; 49:193-200. (Pubitemid 46360360)
11. Vignon-Zellweger N, Relle K, Kienlen E, Alter M, Seider P, Sharkovska J, et al. Endothelin-1 overexpression restores diastolic function in eNOS knockout mice. J Hypertens 2011; 29:961-970.
12. Su Y, Edwards-Bennett S, Bubb MR, Block ER. Regulation of endothelial nitric oxide synthase by the actin cytoskeleton. Am J Physiol Cell Physiol 2003; 284:C1542-C1549. (Pubitemid 36583396)
13. Feron O, Balligand JL. Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc Res 2006; 69:788-797. (Pubitemid 43227977)
14. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 1997; 59:551-571. (Pubitemid 27142455)
15. Reudelhuber TL, Bernstein KE, Delafontaine P. Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look. Hypertension 2007; 49:1196-1201. (Pubitemid 46809352)
16. Caglayan E, Romeo GR, Kappert K, Odenthal M, Sudkamp M, Body SC, et al. Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells. PLoS One 2010; 5:e13608.
17. Elnakish MT, Hassanain HH, Janssen PM. vascular remodeling-associated hypertension leads to left ventricular hypertrophy and contractile dysfunction in Profilin-1 transgenic mice. J Cardiovasc Pharmacol 2012; 60:544-552.
18. Ozaki M, Kawashima S, Yamashita T, Hirase T, Ohashi Y, Inoue N, et al. Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ J 2002; 66:851-856. (Pubitemid 34988223)
19. Paulis L, Simko F. LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodeling. Hypertension 2007; 50:1009-1011. (Pubitemid 350172920)
20. Fujimoto T, Miyawaki A, Mikoshiba K. Inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae is linked to actin filaments. J Cell Sci 1995; 108 (Pt 1):7-15.
21. Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR, et al. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem 2006; 281:26391-26399. (Pubitemid 44401847)
22. Hare JM, Lofthouse RA, Juang GJ, Colman L, Ricker KM, Kim B, et al. Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure. Circ Res 2000; 86:1085-1092. (Pubitemid 30367868)
23. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, et al. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 2002; 277:38988-38997. (Pubitemid 35154765)
24. Piech A, Massart PE, Dessy C, Feron O, Havaux X, Morel N, et al. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2002; 282:H219-H231. (Pubitemid 34654153)
25. Piech A, Dessy C, Havaux X, Feron O, Balligand JL. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc Res 2003; 57:456-467. (Pubitemid 36144224)